These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32542667)

  • 1. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
    Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
    Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
    Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
    Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate.
    Handisurya A; Steiner GE; Stix U; Ecker RC; Pfaffeneder-Mantai S; Langer D; Kramer G; Memaran-Dadgar N; Marberger M
    Prostate; 2001 Dec; 49(4):251-62. PubMed ID: 11746271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.
    Singh RK; Lokeshwar BL
    Cancer Res; 2011 May; 71(9):3268-77. PubMed ID: 21398406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
    Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
    Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
    Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
    Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
    Wang K; Pascal LE; Li F; Chen W; Dhir R; Balasubramani GK; DeFranco DB; Yoshimura N; He D; Wang Z
    Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.
    Zhang B; Kwon OJ; Henry G; Malewska A; Wei X; Zhang L; Brinkley W; Zhang Y; Castro PD; Titus M; Chen R; Sayeeduddin M; Raj GV; Mauck R; Roehrborn C; Creighton CJ; Strand DW; Ittmann MM; Xin L
    Mol Cell; 2016 Sep; 63(6):976-89. PubMed ID: 27594448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
    Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
    Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
    Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
    Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
    Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
    Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2000 Jul; 157(1):249-55. PubMed ID: 10880394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
    Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
    Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.